Podcast Episodes
Back to Search
EULAR 2025 – RA Panel Discussion
Episode 1347
Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this i…
11 months, 2 weeks ago
EULAR2025 Topic Podcast IL-17
Episode 1346
Efficacy and Safety of Xeligekimab in AS
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Novel Therapies in Axial Spondyloarthritis
11 months, 2 weeks ago
EULAR2025 Topic Podcast RA2
Episode 1345
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
Al…
11 months, 2 weeks ago
EULAR2025 Topic Podcast RA1
Episode 1344
Who/When to Treat Clinically Suspect Arthralgia
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
The Impact of Biologics on Methotrexa…
11 months, 2 weeks ago
EULAR2025 Topic Podcast SpA
Episode 1343
Efficacy and Safety of Xeligekimab in AS
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-ax…
11 months, 2 weeks ago
EULAR2025 Topic Podcast PsA 2
Episode 1342
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Biologic Switc…
11 months, 2 weeks ago
EULAR2025 Topic Podcast PsA 1
Episode 1341
EULAR 2025 - Day 1 podcasts
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Using Combination csDMARDs in PsA
Deucravacitinib's Place in the …
11 months, 2 weeks ago
EULAR 2025 - Day 5 podcast
Episode 1340
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
GLP 1 Receptor A…
11 months, 2 weeks ago
EULAR 2025 - Day 4 podcast
Episode 1339
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Emerging Thera…
11 months, 2 weeks ago